olmesartan medoxomil
- Product NDC
- 42291-543
- 11-digit product format
- 422910543
- Labeler code
- 42291
- Product ID
- 42291-543_d57d3921-085b-6640-e053-2a95a90a6116
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- olmesartan medoxomil
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Labeler
- AvKARE
- Application
- ANDA208130
- Marketing category
- ANDA
- Marketing start
- 2018-09-17
- Marketing end
- 0000-00-00
- Substance
- OLMESARTAN MEDOXOMIL
- Active strength
- 20 mg/1
- Pharmacologic classes
- Angiotensin 2 Receptor Antagonists [MoA],Angiotensin 2 Receptor Blocker [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
NDC auxiliary status#
These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.
| Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Source date |
|---|---|---|---|---|---|---|---|
| excluded product | product | 42291-543 | D | Discontinued by firm | 2026-08-03 | ||
| excluded package | package | 42291-543 | 42291-543-30 | D | Discontinued by firm | 2026-08-03 |
Observed NDC auxiliary status history#
This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
| Captured / source date | Dataset | Scope | Package NDC | Snapshot | Source SHA-256 |
|---|---|---|---|---|---|
| 2025-12-14 17:58 UTC · source 2025-12-05 | excluded product | product | d630ba8d3edf… | 732f749b63fb… | |
| 2025-12-14 17:58 UTC · source 2025-12-05 | excluded package | package | 42291-543-30 | d630ba8d3edf… | 732f749b63fb… |
| 2025-08-27 00:01 UTC · source 2025-08-26 | excluded product | product | f5e01cc5f278… | a2eaf40c39c3… | |
| 2025-08-27 00:01 UTC · source 2025-08-26 | excluded package | package | 42291-543-30 | f5e01cc5f278… | a2eaf40c39c3… |
| 2025-04-01 02:39 UTC · source 2025-03-31 | excluded product | product | 2ef7874e63bc… | 57b86245f4fa… | |
| 2025-04-01 02:39 UTC · source 2025-03-31 | excluded package | package | 42291-543-30 | 2ef7874e63bc… | 57b86245f4fa… |
| 2025-03-28 20:22 UTC · source 2025-03-28 | excluded product | product | a1b67e2a42f9… | c4cf2c586c0d… | |
| 2025-03-28 20:22 UTC · source 2025-03-28 | excluded package | package | 42291-543-30 | a1b67e2a42f9… | c4cf2c586c0d… |
| 2025-03-22 03:12 UTC · source 2025-03-21 | excluded product | product | cfe11265f3b6… | 090c488252e2… | |
| 2025-03-22 03:12 UTC · source 2025-03-21 | excluded package | package | 42291-543-30 | cfe11265f3b6… | 090c488252e2… |
| 2025-03-10 12:48 UTC · source 2025-03-10 | excluded product | product | cdf11ea48f46… | ba0047e9e063… | |
| 2025-03-10 12:48 UTC · source 2025-03-10 | excluded package | package | 42291-543-30 | cdf11ea48f46… | ba0047e9e063… |
| 2025-02-02 03:52 UTC · source 2025-01-31 | excluded product | product | 302b2466d912… | e7b80fea0513… | |
| 2025-02-02 03:52 UTC · source 2025-01-31 | excluded package | package | 42291-543-30 | 302b2466d912… | e7b80fea0513… |
| 2025-01-20 13:05 UTC · source 2025-01-20 | excluded product | product | ed331223b511… | 672a5bd82f5f… | |
| 2025-01-20 13:05 UTC · source 2025-01-20 | excluded package | package | 42291-543-30 | ed331223b511… | 672a5bd82f5f… |
| 2025-01-11 03:41 UTC · source 2025-01-10 | excluded product | product | 0efc9e666f02… | f202fb6c5f17… | |
| 2025-01-11 03:41 UTC · source 2025-01-10 | excluded package | package | 42291-543-30 | 0efc9e666f02… | f202fb6c5f17… |
| 2024-11-09 02:27 UTC · source 2024-11-08 | excluded product | product | ad56d346431e… | cc804d4bbf1e… | |
| 2024-11-09 02:27 UTC · source 2024-11-08 | excluded package | package | 42291-543-30 | ad56d346431e… | cc804d4bbf1e… |
| 2024-10-04 04:10 UTC · source 2024-10-03 | excluded product | product | 367a005e9d99… | 383a685ebd0f… | |
| 2024-10-04 04:10 UTC · source 2024-10-03 | excluded package | package | 42291-543-30 | 367a005e9d99… | 383a685ebd0f… |
| 2024-07-10 04:00 UTC · source 2024-07-09 | excluded product | product | 557ba5c1ecfa… | 9c80585c8c6e… | |
| 2024-07-10 04:00 UTC · source 2024-07-09 | excluded package | package | 42291-543-30 | 557ba5c1ecfa… | 9c80585c8c6e… |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A208130-001 | OLMESARTAN MEDOXOMIL | OLMESARTAN MEDOXOMIL | 5MG | TABLET / ORAL | AB | 2018-06-29 | |
| A208130-002 | OLMESARTAN MEDOXOMIL | OLMESARTAN MEDOXOMIL | 20MG | TABLET / ORAL | AB | 2018-06-29 | |
| A208130-003 | OLMESARTAN MEDOXOMIL | OLMESARTAN MEDOXOMIL | 40MG | TABLET / ORAL | AB | 2018-06-29 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A208130-001 | AB |
| A208130-002 | AB |
| A208130-003 | AB |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | A208130-001 | OLMESARTAN MEDOXOMIL | 5MG | TABLET / ORAL | AB | 2018-06-29 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A208130-002 | OLMESARTAN MEDOXOMIL | 20MG | TABLET / ORAL | AB | 2018-06-29 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A208130-003 | OLMESARTAN MEDOXOMIL | 40MG | TABLET / ORAL | AB | 2018-06-29 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A208130-001 | OLMESARTAN MEDOXOMIL | 5MG | TABLET / ORAL | AB | 2018-06-29 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A208130-002 | OLMESARTAN MEDOXOMIL | 20MG | TABLET / ORAL | AB | 2018-06-29 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A208130-003 | OLMESARTAN MEDOXOMIL | 40MG | TABLET / ORAL | AB | 2018-06-29 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | A208130-001 | OLMESARTAN MEDOXOMIL | 5MG | TABLET / ORAL | AB | 2018-06-29 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A208130-002 | OLMESARTAN MEDOXOMIL | 20MG | TABLET / ORAL | AB | 2018-06-29 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A208130-003 | OLMESARTAN MEDOXOMIL | 40MG | TABLET / ORAL | AB | 2018-06-29 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A208130-001 | OLMESARTAN MEDOXOMIL | 5MG | TABLET / ORAL | AB | 2018-06-29 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A208130-002 | OLMESARTAN MEDOXOMIL | 20MG | TABLET / ORAL | AB | 2018-06-29 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A208130-003 | OLMESARTAN MEDOXOMIL | 40MG | TABLET / ORAL | AB | 2018-06-29 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A208130-001 | OLMESARTAN MEDOXOMIL | 5MG | TABLET / ORAL | AB | 2018-06-29 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A208130-002 | OLMESARTAN MEDOXOMIL | 20MG | TABLET / ORAL | AB | 2018-06-29 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A208130-003 | OLMESARTAN MEDOXOMIL | 40MG | TABLET / ORAL | AB | 2018-06-29 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A208130-001 | OLMESARTAN MEDOXOMIL | 5MG | TABLET / ORAL | AB | 2018-06-29 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A208130-002 | OLMESARTAN MEDOXOMIL | 20MG | TABLET / ORAL | AB | 2018-06-29 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A208130-003 | OLMESARTAN MEDOXOMIL | 40MG | TABLET / ORAL | AB | 2018-06-29 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A208130-001 | OLMESARTAN MEDOXOMIL | 5MG | TABLET / ORAL | AB | 2018-06-29 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A208130-002 | OLMESARTAN MEDOXOMIL | 20MG | TABLET / ORAL | AB | 2018-06-29 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A208130-003 | OLMESARTAN MEDOXOMIL | 40MG | TABLET / ORAL | AB | 2018-06-29 | 2680178bc6a6… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A208130-001 | OLMESARTAN MEDOXOMIL | 5MG | TABLET / ORAL | AB | 2018-06-29 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A208130-002 | OLMESARTAN MEDOXOMIL | 20MG | TABLET / ORAL | AB | 2018-06-29 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A208130-003 | OLMESARTAN MEDOXOMIL | 40MG | TABLET / ORAL | AB | 2018-06-29 | 5bbf6a4d5a75… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A208130-001 | OLMESARTAN MEDOXOMIL | 5MG | TABLET / ORAL | AB | 2018-06-29 | d8e5a09893c0… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A208130-002 | OLMESARTAN MEDOXOMIL | 20MG | TABLET / ORAL | AB | 2018-06-29 | d8e5a09893c0… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A208130-003 | OLMESARTAN MEDOXOMIL | 40MG | TABLET / ORAL | AB | 2018-06-29 | d8e5a09893c0… | |
| 2024-10-29 15:01 UTC | 2024-10 | A208130-001 | OLMESARTAN MEDOXOMIL | 5MG | TABLET / ORAL | AB | 2018-06-29 | d06236e962d9… | |
| 2024-10-29 15:01 UTC | 2024-10 | A208130-002 | OLMESARTAN MEDOXOMIL | 20MG | TABLET / ORAL | AB | 2018-06-29 | d06236e962d9… | |
| 2024-10-29 15:01 UTC | 2024-10 | A208130-003 | OLMESARTAN MEDOXOMIL | 40MG | TABLET / ORAL | AB | 2018-06-29 | d06236e962d9… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A208130-001 | OLMESARTAN MEDOXOMIL | 5MG | TABLET / ORAL | AB | 2018-06-29 | 79d66fd596c7… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A208130-002 | OLMESARTAN MEDOXOMIL | 20MG | TABLET / ORAL | AB | 2018-06-29 | 79d66fd596c7… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A208130-003 | OLMESARTAN MEDOXOMIL | 40MG | TABLET / ORAL | AB | 2018-06-29 | 79d66fd596c7… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A208130-001 | OLMESARTAN MEDOXOMIL | 5MG | TABLET / ORAL | AB | 2018-06-29 | 301d65b070ca… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A208130-002 | OLMESARTAN MEDOXOMIL | 20MG | TABLET / ORAL | AB | 2018-06-29 | 301d65b070ca… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A208130-003 | OLMESARTAN MEDOXOMIL | 40MG | TABLET / ORAL | AB | 2018-06-29 | 301d65b070ca… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A208130-001 | OLMESARTAN MEDOXOMIL | 5MG | TABLET / ORAL | AB | 2018-06-29 | 1e350fbaab3a… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A208130-002 | OLMESARTAN MEDOXOMIL | 20MG | TABLET / ORAL | AB | 2018-06-29 | 1e350fbaab3a… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A208130-003 | OLMESARTAN MEDOXOMIL | 40MG | TABLET / ORAL | AB | 2018-06-29 | 1e350fbaab3a… | |
| 2024-05-31 18:47 UTC | 2024-05 | A208130-001 | OLMESARTAN MEDOXOMIL | 5MG | TABLET / ORAL | AB | 2018-06-29 | 8072bd15b7f6… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | A208130-001 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A208130-002 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A208130-003 | AB | 1 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A208130-001 | AB | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A208130-002 | AB | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A208130-003 | AB | 1 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | A208130-001 | AB | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | A208130-002 | AB | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | A208130-003 | AB | 1 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A208130-001 | AB | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A208130-002 | AB | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A208130-003 | AB | 1 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A208130-001 | AB | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A208130-002 | AB | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A208130-003 | AB | 1 | b8a1b40f171c… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A208130-001 | AB | 1 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A208130-002 | AB | 1 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A208130-003 | AB | 1 | 03ed91905a0d… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A208130-001 | AB | 1 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A208130-002 | AB | 1 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A208130-003 | AB | 1 | 2680178bc6a6… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A208130-001 | AB | 1 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A208130-002 | AB | 1 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A208130-003 | AB | 1 | 5bbf6a4d5a75… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A208130-001 | AB | 1 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A208130-002 | AB | 1 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A208130-003 | AB | 1 | d8e5a09893c0… |
| 2024-10-29 15:01 UTC | 2024-10 | A208130-001 | AB | 1 | d06236e962d9… |
| 2024-10-29 15:01 UTC | 2024-10 | A208130-002 | AB | 1 | d06236e962d9… |
| 2024-10-29 15:01 UTC | 2024-10 | A208130-003 | AB | 1 | d06236e962d9… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A208130-001 | AB | 1 | 79d66fd596c7… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A208130-002 | AB | 1 | 79d66fd596c7… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A208130-003 | AB | 1 | 79d66fd596c7… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A208130-001 | AB | 1 | 301d65b070ca… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A208130-002 | AB | 1 | 301d65b070ca… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A208130-003 | AB | 1 | 301d65b070ca… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A208130-001 | AB | 1 | 1e350fbaab3a… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A208130-002 | AB | 1 | 1e350fbaab3a… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A208130-003 | AB | 1 | 1e350fbaab3a… |
| 2024-05-31 18:47 UTC | 2024-05 | A208130-001 | AB | 1 | 8072bd15b7f6… |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 42291-543-30 | EA - Each | 42291-543 | 4a48a7fb-4a7c-4a34-a242-f5b75686a726 | 1 | 2018-11-06 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Olmesartan Medoxomil | OLMESARTAN MEDOXOMIL | Direct_Rx | 4a2aad53-fcba-2a61-e063-6394a90a6016 | 2026-06-23 | Boxed warning, Warnings, Adverse reactions | 208130 ANDA208130 |
| olmesartan medoxomil | OLMESARTAN MEDOXOMIL | REMEDYREPACK INC. | fe6e39da-fb6e-46da-9c03-c765020a7c87 | 2026-06-12 | Boxed warning, Warnings, Adverse reactions | 208130 ANDA208130 |
| olmesartan medoxomil | OLMESARTAN MEDOXOMIL | Golden State Medical Supply, Inc. | 865c2765-5072-d029-e053-2a91aa0a098e | 2025-11-25 | Boxed warning, Warnings, Adverse reactions | 208130 ANDA208130 |
| olmesartan medoxomil | OLMESARTAN MEDOXOMIL | Bryant Ranch Prepack | 8466711a-3a02-4675-96db-c7cffdb89778 | 2025-11-10 | Boxed warning, Warnings, Adverse reactions | 208130 ANDA208130 |
| olmesartan medoxomil | OLMESARTAN MEDOXOMIL | Bryant Ranch Prepack | 640936ee-55a6-47ae-a1ad-cffae316b925 | 2025-10-13 | Boxed warning, Warnings, Adverse reactions | 208130 ANDA208130 |
| olmesartan medoxomil | OLMESARTAN MEDOXOMIL | REMEDYREPACK INC. | 1be698df-30a0-4117-8c24-7253af94c8ad | 2025-09-25 | Boxed warning, Warnings, Adverse reactions | 208130 ANDA208130 |
| olmesartan medoxomil | OLMESARTAN MEDOXOMIL | Bryant Ranch Prepack | 25431c8c-9f6e-42e7-ab84-4b062755bfe3 | 2024-05-29 | Boxed warning, Warnings, Adverse reactions | 208130 ANDA208130 |
| olmesartan medoxomil | OLMESARTAN MEDOXOMIL | Bryant Ranch Prepack | fe80fd21-fa8d-474e-ac0a-23f0e1eb7f3b | 2024-01-11 | Boxed warning, Warnings, Adverse reactions | 208130 ANDA208130 |
| olmesartan medoxomil | OLMESARTAN MEDOXOMIL | Bryant Ranch Prepack | c35408d2-a4b5-43de-8dab-f74a60fa9853 | 2024-01-11 | Boxed warning, Warnings, Adverse reactions | 208130 ANDA208130 |
| olmesartan medoxomil | OLMESARTAN MEDOXOMIL | Bryant Ranch Prepack | 409e06ad-2ea9-4b47-829e-57139e22eac9 | 2023-06-05 | Boxed warning, Warnings, Adverse reactions | 208130 ANDA208130 |
| olmesartan medoxomil | OLMESARTAN MEDOXOMIL | ScieGen Pharmaceuticals, Inc. | f15664a4-6b5f-4e88-ad56-c827ed90a40c | 2021-01-08 | Boxed warning, Warnings, Adverse reactions | 208130 ANDA208130 |
Packages#
| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|
| 42291-543-30 | 42291054330 | 30 TABLET, FILM COATED in 1 BOTTLE (42291-543-30) | 2018-09-17 | 0000-00-00 | No | No | Current |